Studies
Boston Scientific | MOAB | NCT06511141
Male Overactive Bladder
Calyxo | SCORE | NCT07155005
Renal Stones
CG Oncology | CORE-008 | NCT06567743
High Risk Non-Muscle Invasive Bladder Cancer
CG Oncology | CRETO-EAP | NCT06443944
High Risk Non-Muscle Invasive Bladder Cancer
Dendreon ProvONE NCT06134232
Metastatic Castrate-Resistant Prostate Cancer
Ferring | ABLE-32 | NCT06510374
Intermediate Risk Non-Muscle Invasive Bladder Cancer
ImmunityBio | ResQ132EX | NCT06810141
High Risk Non-Muscle Invasive Bladder Cancer
Pfizer | MEVPRO-3 | NCT07028853
Metastatic Castrate-Sensitive Prostate Cancer
Procept BioRobotics | WATER IV | NCT06651632
Localized Prostate Cancer
Protara | ADVANCED-3 | NCT07480356
High Risk Non-Muscle Invasive Bladder Cancer